← 홈

프로그램 비교

검색으로 10,000+ 프로그램 중 최대 5개를 골라 PK/PD · 독성 · 임상을 나란히 비교합니다. · 다음 갱신 D-13 · 마지막 7월 13일

현재 선택: 1

프로그램 상세에서 관심 등록 후 2개 이상 모으면 여기서 한 번에 비교할 수 있습니다.

API CSV20행 · 1개 프로그램

표가 넓으면 좌우로 스크롤하세요. 핵심 비교 모드에서는 중요 항목만 표시됩니다.

항목
CGTPhase 2
Propranolol (Propranolol)
Janssen Research & Development, LL…·Advanced Melanoma
ORR 17%
Overview
Program
Propranolol
Overview
Company
Janssen Research & Development, LLC
Overview
Modality
CGT
Overview
Target
Advanced Melanoma
Overview
Indication
Carcinoma, Non-Small-Cell Lung
Overview
Phase
PHASE_2
Overview
Status
RECRUITING
MoA
Biomarker
biomarker analyses
PK/PD
Species
Mouse
PK/PD
Animal (cat.)
Mouse
PK/PD
Experiment
pharmacokinetic
Toxicology
Species
Mouse
Toxicology
Animal (cat.)
Mouse
Toxicology
Major finding
Iatrogenic harm in paediatric and adolescent populations of patients with migraine: A systematic review with meta-analysis.. BackgroundMigraine is a common condition that causes a high burden of disability even at a young age, significantly affecting various aspects of quality of life. Despite this significant burden, the pharmacological treatment of migraine is still a subject of debate, with con…
Clinical
Primary efficacy
ORR 17%
Clinical
ORR
17%
Clinical
Result source
ClinicalTrials.gov NCT04299438
Clinical
Data Tier / Score
A · 40
Clinical
Program phase
PHASE_2
Clinical
Clinical sync
2026년 7월 12일 (2일 전)